Zepbound (tirzepatide, Eli Lilly)
- Weekly · vial or KwikPen
- Self-pay $299 to $449/mo (LillyDirect)
- Also approved for moderate to severe obstructive sleep apnea in adults with obesity
Prices checked Oct 2026 · US
Three injections are FDA-approved for weight loss as of October 2026: Zepbound, Wegovy and Saxenda. Self-pay for Wegovy and Zepbound runs $199 to $449 a month; trial averages were about 15% to 21%.
Ro Body has an insurance concierge and sells Wegovy, Zepbound and Foundayo at manufacturer self-pay prices ($39 first month, then $149/mo membership).
We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure
Chia Health
Our #1 pick for GLP-1 weight loss online
Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure
$212.89 first month, then $349/mo
6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.
00 At a glance
Three prescription shots carry an FDA label for chronic weight management. All are GLP-1 based pens used with diet and activity; they differ in strength, how often you inject and price.
Compounded semaglutide and tirzepatide are sold by some telehealth clinics (median $175 and $222 a month in an October 2026 index), but they are not FDA-approved and have no pivotal trials behind the specific product you receive.
01 Prices
These are the manufacturer self-pay prices we checked on NovoCare and Lilly's Zepbound savings page in October 2026. Savings cards only apply if you have commercial insurance. The Medicare GLP-1 Bridge runs Jul 1, 2026 to Dec 31, 2027.
| Shot | Dose | Self-pay (no insurance) | Commercial insurance + savings card | Medicare GLP-1 Bridge |
|---|---|---|---|---|
| Wegovy pen Insurance + card: As little as $25 (max savings $100/mo) · Medicare: $50/mo | 0.25 and 0.5 mg, first 2 fills | $199/mo | As little as $25 (max savings $100/mo) | $50/mo |
| Wegovy pen Insurance + card: As little as $25 · Medicare: $50/mo | 0.25 to 2.4 mg | $349/mo | As little as $25 | $50/mo |
| Wegovy HD Insurance + card: As little as $25 · Medicare: $50/mo | 7.2 mg | $399/mo | As little as $25 | $50/mo |
| Zepbound Insurance + card: $25 if your plan covers it · Medicare: $50/mo (KwikPen only) | 2.5 mg | $299/mo | $25 if your plan covers it | $50/mo (KwikPen only) |
| Zepbound Insurance + card: $25 if your plan covers it · Medicare: $50/mo (KwikPen only) | 5 mg | $399/mo | $25 if your plan covers it | $50/mo (KwikPen only) |
| Zepbound Insurance + card: $25 if your plan covers it · Medicare: $50/mo (KwikPen only) | 7.5 to 15 mg | $449/mo* | $25 if your plan covers it | $50/mo (KwikPen only) |
| Saxenda Insurance + card: Savings offer closed to new enrollees · Medicare: Not in the Bridge | 0.6 to 3 mg daily | No self-pay program | Savings offer closed to new enrollees | Not in the Bridge |
Without insurance, the cheapest entry is Wegovy at $199 for the first two months; at maintenance doses it is $349 versus $449 for Zepbound 7.5 mg and up. Full breakdowns: Wegovy cost, Zepbound cost, GLP-1 cost with insurance.
02 Names
Five names come up most. Only three are approved for weight loss; the other two share their molecules but carry a type 2 diabetes label.
Teva has sold a generic version of liraglutide since August 2025. Names you may see in news but cannot buy as an approved weight loss shot yet: CagriSema (Novo, FDA decision expected Q4 2026) and retatrutide (Lilly, filing planned Q1 2027). Neither is FDA-approved as of Oct 17, 2026.
03 Ranking
We rank by average weight loss in each drug's pivotal trial. Trials differ in length and population, so this is a guide, not a head-to-head result. The one head-to-head trial, SURMOUNT-5 (NEJM 2025), found 20.2% loss on tirzepatide versus 13.7% on semaglutide at 72 weeks.
SURMOUNT-1, 72 weeks. 10 mg gave 19.5%, 5 mg gave 15.0%. Weekly, $299 to $449/mo.
STEP 1, 68 weeks, versus 2.4% on placebo. Weekly, $349/mo. The newer 7.2 mg Wegovy HD averaged 18.8% in STEP UP (intention-to-treat, 72 weeks), for people already on 2.4 mg; see Wegovy HD.
SCALE, 56 weeks. Daily. With no savings program and a discontinuation already announced, it is mostly a fallback when weekly shots are not an option.
Average trial results, not a promise. Lilly's September 2026 analysis comparing Zepbound 15 mg with Wegovy HD 7.2 mg was indirect (two separate trials), and the gap shrank under a second statistical method.
Best on average loss: Zepbound. Cheapest to start and broadest label: Wegovy. Ranking with pills included: best prescription weight loss medication.
04 Diabetes vs weight loss
Ozempic and Wegovy are the same molecule. So are Mounjaro and Zepbound. What changes is the FDA label, the top dose and the price, and the label decides what your insurer will pay for.
| Ozempic | Wegovy | |
|---|---|---|
| FDA label | Type 2 diabetes | Weight loss, heart risk, MASH |
| Top dose | 2 mg | 2.4 mg (HD 7.2 mg) |
| Self-pay | $349 (to 1 mg) to $499 (2 mg) | $349 ($199 first 2 fills) |
| Trial result | about 4.5 kg at 1 mg (SUSTAIN, diabetes) | 14.9% (STEP 1) |
| Mounjaro | Zepbound | |
|---|---|---|
| FDA label | Type 2 diabetes, CV risk in T2D (Aug 2026) | Weight loss, sleep apnea |
| Self-pay | No LillyDirect price | $299 to $449 |
| Savings card, no coverage | $499 minimum | $299 (KwikPen) |
| Trial result | diabetes trials | up to 20.9% (SURMOUNT-1) |
Without type 2 diabetes, Wegovy and Zepbound are the on-label choice and, in October 2026, the cheaper self-pay option. Full guide: diabetic shots for weight loss.
05 How they work
All three injections for weight loss copy GLP-1, a gut hormone released after eating, to slow stomach emptying and lower appetite. Tirzepatide (Zepbound) also activates GIP receptors, the usual explanation for its larger average loss.
Belly, thigh or upper arm, with a prefilled pen or vial.
Wegovy and Zepbound once a week, Saxenda once a day.
Every label starts low and steps up (every 4 weeks for Wegovy and Zepbound, weekly for Saxenda) to limit stomach side effects; your prescriber sets your dose.
How to inject and how the pens differ: GLP-1 injections, how pens work.
06 Eligibility
Per the FDA labels, adults qualify for Wegovy, Zepbound or Saxenda with either of these:
Weight-related condition: for example high blood pressure, type 2 diabetes, high cholesterol.
Check your number with the BMI calculator. Medicare's Bridge and many insurers use stricter rules.
07 Side effects
Most weight loss shots side effects are stomach-related and show up while the dose is being raised. The numbers below come from the FDA labels, pooled from the weight loss trials.
| Side effect | Wegovy 2.4 mg | Placebo (Wegovy trials) | Zepbound 15 mg | Placebo (Zepbound trials) |
|---|---|---|---|---|
| Nausea | 44% | 16% | 28% | 8% |
| Diarrhea | 30% | 16% | 23% | 8% |
| Vomiting | 24% | 6% | 13% | 2% |
| Constipation | 24% | 11% | 11% | 5% |
| Abdominal pain | 20% | 10% | 10% | 5% |
| Stopped due to side effects | 6.8% | 3.2% | 6.7% | 3.4% |
Compare each drug with its own placebo, not across columns: the trials were separate. Zepbound 5 and 10 mg had similar rates (nausea 25% and 29%).
Rare but serious. All three labels carry a boxed warning for thyroid C-cell tumors seen in rodents, and list pancreatitis, gallbladder problems, acute kidney injury from dehydration and severe stomach reactions. In January 2026 the FDA asked Novo and Lilly to remove the suicidal-ideation warning from Wegovy, Zepbound and Saxenda after a review of 91 trials with 107,910 patients found no increased risk. On Oct 10, 2026 the FDA said it is running its own study of GLP-1 drugs and NAION, a rare form of sudden vision loss; US labels carry no NAION warning yet (FDA NAION study). Label changes are tracked in GLP-1 news; a symptom-by-symptom guide is on Ozempic side effects.
08 Steps
BMI 30+, or 27+ with a weight-related condition. Two minutes with the BMI calculator.
Your own doctor or an obesity specialist, or a US telehealth clinic: Ro and Hers charge $39 the first month, then $149/mo; PlushCare $129 per visit without insurance. Options near you: GLP-1 access by state.
Ask your plan whether it covers Wegovy or Zepbound for weight and whether it needs prior authorization. With coverage, the savings cards bring the copay to as little as $25. On Medicare, ask about the $50 Bridge.
Self-pay fills go through NovoCare Pharmacy (Wegovy) or LillyDirect (Zepbound), at the prices in the table above. Insured fills go to your pharmacy. For Zepbound's $449 tier, refill within 45 days.
Related: weight loss shots for women covers PCOS, menopause and pregnancy planning.
09 Shot or pill
The Wegovy pill (approved Dec 22, 2025) and Foundayo (orforglipron, approved Apr 1, 2026) are FDA-approved for weight loss too, but they are daily tablets, not shots, so the count of approved injections stays at three.
| Weekly shot | Daily pill | |
|---|---|---|
| Options | Wegovy, Zepbound (Saxenda is daily) | Wegovy pill, Foundayo |
| Self-pay | $199 (first 2 Wegovy fills) to $449/mo | $149 to $299/mo |
| Trial loss | 14.9% (STEP 1) to 20.9% (SURMOUNT-1) | 13.6% Wegovy pill 25 mg (OASIS 4), 11.1% Foundayo top dose (ATTAIN-1) |
| Medicare Bridge | Wegovy pen, Zepbound KwikPen | Wegovy pill, Foundayo |
Shots lead on average loss; pills cost less to start and skip the needle. Details: Wegovy pill, Foundayo, Wegovy pill vs injection, GLP-1 pills compared.
10 Telehealth
Clinics compared on price, FDA-approved shots offered, insurance help and clinical oversight (prices read on each provider's page, Oct 2026).
| Provider | Type | Month 1 total | Regular monthly | Prepay | Insurance | Next step |
|---|---|---|---|---|---|---|
| #1 Chia Health Compounded semaglutide injection, month-to-month planPrices checked Nov 17, 2026 | Compounded all-in | Month 1$212.89 | Regular$349/mo | Prepay6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months) | InsuranceNo | Get Started Read review of Chia Health |
| #2 TrimRx Compounded semaglutide: $89 Black Friday ad price (billed upfront, to about Dec 1), $199 in its termsPrices checked Nov 17, 2026 | Brand-name Compounded all-in | Month 1$89 to $199 | Regular$299/mo | PrepayNot published | InsuranceNo | Check eligibility Read review of TrimRx |
| #3 Mochi Health Compounded semaglutide at the lowest dose; price rises with dosePrices checked Nov 17, 2026 | Brand-name Compounded membership + medication | Month 1$60 | Regular$139/mo | Prepay12-month plan: $109/mo ($588 membership upfront) | InsuranceYes | Check eligibility Read review of Mochi Health |
| #4 Ro Body Wegovy pill 1.5 mg + Ro Body membershipPrices checked Nov 17, 2026 | Brand-name membership + medication | Month 1$188 | Regular$298/mo | Prepay12-month prepaid plan: $223/mo | InsuranceYes | Check eligibility Read review of Ro Body |
| #5 Henry Meds Compounded semaglutide injection, weeklyPrices checked Nov 17, 2026 | Compounded all-in | Month 1$297 | Regular$297/mo | Prepay12-month plan: about $197/mo ($2,364 upfront) | InsuranceNo | Check eligibility Read review of Henry Meds |
Month 1 total and Regular monthly = every clinic fee plus the medication named under each clinic, month to month, before insurance; microdose plans left out. Compounded = not FDA-approved. The clinic's checkout is final.
Provider reviews: Ro GLP-1 reviews · how much does Hers cost · PlushCare
11 FAQ
Ro's insurance concierge checks coverage for Wegovy and Zepbound. If the plan says no, Ro sells both at manufacturer self-pay prices.
Start a Ro coverage checkThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Last updated Nov 17, 2026 · Prices checked Oct 2026 on NovoCare, Lilly and CMS.